However, in a study by Matsumoto et al., the enlargement of RPE atrophy was positively associated with the number of anti-VEGF injections in type 3 MNV11, suggesting that the influence of anti-VEGF injections on RPE atrophy should not be completely neglected, at least in type 3 MNV. This evidence concerns the gene VEGFA and Atrophy.